CDKN2B antibody (C-Term)
Quick Overview for CDKN2B antibody (C-Term) (ABIN6735853)
Target
See all CDKN2B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human CDKN2B / p15 INK4b
-
Predicted Reactivity
- Percent identity by BLAST analysis: Pig (100%) Dog, Rabbit (91%) Mouse, Rat, Guinea pig (83%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human CDKN2B (P42772, NP_004927). Percent identity by BLAST analysis: Human, Chimpanzee, Gibbon, Monkey, Elephant, Bovine, Rabbit, Pig (100%), Gorilla, Marmoset, Panda, Dog, Horse, Guinea pig (91%), Bat (90%), Mouse, Rat (83%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: WB (0.2 - 1 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Alternative Name
- CDKN2B / p15 INK4b
-
Background
-
Name/Gene ID: CDKN2B
Synonyms: CDKN2B, CDK inhibitory protein, CDK4B inhibitor, INK4B, MTS2, Multiple tumor suppressor 2, p14_INK4B, p15, p14_CDK inhibitor, p15 CDK inhibitor, p15 INK4b, p15-INK4b, p15_INK4B, p14-INK4b, p15INK4b, CDK4I, MTS-2, TP15 -
Gene ID
- 1030
-
NCBI Accession
- NP_004927
-
UniProt
- P42772
-
Pathways
- Cell Division Cycle, Mitotic G1-G1/S Phases
Target
-